TipRanks (Tue, 15-Sep 10:50 AM ET)
Business Wire (Tue, 15-Sep 10:19 AM ET)
Business Wire (Tue, 15-Sep 9:00 AM ET)
Chamberlain University Names Jason Dunne Chief Academic Officer
Business Wire (Mon, 14-Sep 8:00 AM ET)
Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort
Business Wire (Wed, 9-Sep 9:00 AM ET)
Covista to Participate in September Investor Conferences
Business Wire (Tue, 8-Sep 8:00 AM ET)
Business Wire (Thu, 20-Aug 4:00 PM ET)
Business Wire (Thu, 6-Aug 4:05 PM ET)
Covista Expands and Strengthens Leadership Bench to Accelerate Purpose at Scale
Business Wire (Wed, 5-Aug 9:00 AM ET)
Covista Names Emily C. Chiu and Leslie Storms to its Board of Directors
Business Wire (Tue, 28-Jul 8:00 AM ET)
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
Covista Common Shares trades on the NYSE stock market under the symbol CVSA.
As of September 18, 2026, CVSA stock price climbed to $126.72 with 542,415 million shares trading.
CVSA has a beta of 0.31, meaning it tends to be less sensitive to market movements. CVSA has a correlation of 0.01 to the broad based SPY ETF.
CVSA has a market cap of $4.31 billion. This is considered a Mid Cap stock.
Last quarter Covista Common Shares reported $501 million in Revenue and $2.09 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.20.
The top ETF exchange traded funds that CVSA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
CVSA support price is $123.03 and resistance is $129.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVSA shares will trade within this expected range on the day.